Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

Overweight and obesity were significantly associated with memory issues and persistent headache, among other conditions.